EIM
EOLS icon

Essex Investment Management’s Evolus EOLS Stock Holding History

Essex Investment Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-181,134
Closed -$2.18M – 304
2025
Q1 		$2.18M Sell
181,134
-1,369
-0.8% -$17.9K 0.45% 94
2024
Q4 		$2.01M Sell
182,503
-113,050
-38% -$1.59M 0.36% 117
2024
Q3 		$4.79M Buy
295,553
+1,111
+0.4% +$15.5K 0.83% 37
2024
Q2 		$3.19M Buy
294,442
+39,631
+16% +$487K 0.6% 60
2024
Q1 		$3.57M Buy
254,811
+3,761
+1% +$48.9K 0.7% 43
2023
Q4 		$2.64M Sell
251,050
-23,754
-9% -$212K 0.52% 66
2023
Q3 		$2.51M Sell
274,804
-3,574
-1% -$32.1K 0.41% 86
2023
Q2 		$2.02M Buy
278,378
+31,731
+13% +$274K 0.28% 126
2023
Q1 		$2.09M Buy
246,647
+33,751
+16% +$305K 0.3% 108
2022
Q4 		$1.6M Sell
212,896
-155,450
-42% -$1.2M 0.25% 122
2022
Q3 		$2.96M Buy
368,346
+5,565
+2% +$59K 0.47% 66
2022
Q2 		$4.21M Sell
362,781
-8,839
-2% -$104K 0.68% 39
2022
Q1 		$4.17M Buy
+371,620
New +$3.17M 0.52% 51

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Essex Investment Management's EOLS Position: Q2 2025 in Review

Essex Investment Management sold out of Evolus (EOLS) in Q2 2025, closing a stake of 181,134 shares — an estimated $2.18M sold.

Essex Investment Management first reported a position in EOLS in Q1 2022 and held it in 13 quarters. The position peaked at $4.79M in Q3 2024. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Essex Investment Management reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Essex Investment Management sold 181,134 Evolus shares in Q2 2025, an estimated $2.18M.
  • Essex Investment Management first reported a position in Evolus in Q1 2022 and held it in 13 quarters.
  • Essex Investment Management's Evolus position peaked at $4.79M in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Essex Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.